Memphasys Ltd (MEM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.306x

Based on the latest financial reports, Memphasys Ltd (MEM) has a cash flow conversion efficiency ratio of -0.306x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.23 Million ≈ $-871.57K USD) by net assets (AU$4.02 Million ≈ $2.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Memphasys Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Memphasys Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEM total liabilities for a breakdown of total debt and financial obligations.

Memphasys Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Memphasys Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Globe Kita Terang Tbk PT
JK:GLOB
-0.003x
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B
-0.550x
Radiant Utama Interinsco Tbk
JK:RUIS
-0.070x
Ostin Technology Group Co Ltd
NASDAQ:OST
-0.096x
AUX Resources Corporation
V:AUX
-0.314x
Burford Capital Limited
LSE:BUR
0.048x
Impax Environmental Markets PLC
LSE:IEM
0.003x
Indo Straits Tbk
JK:PTIS
0.048x

Annual Cash Flow Conversion Efficiency for Memphasys Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Memphasys Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Memphasys Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$5.37 Million
≈ $3.80 Million
AU$-2.41 Million
≈ $-1.71 Million
-0.449x +5.01%
2024-06-30 AU$6.84 Million
≈ $4.84 Million
AU$-3.23 Million
≈ $-2.29 Million
-0.473x -148.09%
2023-06-30 AU$7.38 Million
≈ $5.23 Million
AU$-1.41 Million
≈ $-995.31K
-0.190x -567.12%
2022-06-30 AU$7.65 Million
≈ $5.41 Million
AU$311.82K
≈ $220.63K
0.041x +685.09%
2021-06-30 AU$8.61 Million
≈ $6.09 Million
AU$44.71K
≈ $31.63K
0.005x -57.84%
2020-06-30 AU$9.76 Million
≈ $6.90 Million
AU$120.19K
≈ $85.05K
0.012x +110.57%
2019-06-30 AU$6.07 Million
≈ $4.30 Million
AU$-707.47K
≈ $-500.58K
-0.117x +47.11%
2018-06-30 AU$3.35 Million
≈ $2.37 Million
AU$-738.42K
≈ $-522.48K
-0.220x -107.21%
2017-06-30 AU$-402.24K
≈ $-284.61K
AU$-1.23 Million
≈ $-869.31K
3.054x +455.22%
2016-06-30 AU$1.48 Million
≈ $1.05 Million
AU$-1.27 Million
≈ $-899.02K
-0.860x +73.50%
2015-06-30 AU$746.59K
≈ $528.26K
AU$-2.42 Million
≈ $-1.71 Million
-3.244x -442.08%
2014-06-30 AU$-992.85K
≈ $-702.50K
AU$-941.64K
≈ $-666.27K
0.948x +771.03%
2013-06-30 AU$6.99 Million
≈ $4.95 Million
AU$-987.97K
≈ $-699.05K
-0.141x +1.56%
2012-06-30 AU$4.56 Million
≈ $3.23 Million
AU$-655.09K
≈ $-463.52K
-0.144x +40.80%
2011-06-30 AU$7.00 Million
≈ $4.95 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.243x -18.49%
2010-06-30 AU$12.84 Million
≈ $9.09 Million
AU$-2.63 Million
≈ $-1.86 Million
-0.205x +79.64%
2009-06-30 AU$-398.47K
≈ $-281.94K
AU$400.62K
≈ $283.46K
-1.005x +72.30%
2008-06-30 AU$1.10 Million
≈ $779.28K
AU$-4.00 Million
≈ $-2.83 Million
-3.630x --

About Memphasys Ltd

AU:MEM Australia Medical Devices
Market Cap
$10.07 Million
AU$14.24 Million AUD
Market Cap Rank
#26851 Global
#1334 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.37
About

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more